Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              A Preliminary Analysis of Oral Edaravone-treated Patients with Amyotrophic Lateral Sclerosis Enrolled in a US-based Administrative Claims Database

              Author:Ciepielewska, Malgorzata   Zhang, Jeffrey   Liu, Ying   Da Silva, Polina   

              Session Name:S3: Contemporary Neurology Practice and Emerging Neurologic Therapies  

              Topic:General Neurology  

              Program Number:S3.005  

              Author Institution:Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  Princeton Pharmatech LLC, Princeton, NJ  

              Real-world Evidence on Treatment Retention, Safety, and Tolerability of Edaravone in Canadian Patients with Amyotrophic Lateral Sclerosis

              Author:Pham, Dung   St-Onge, Louise   Ng, Ryan   Neish, Calum S.   Yap, Belinda   Kainth, Pinay   Apple, Stephen   

              Session Name:P5: Neuromuscular and Clinical Neurophysiology (EMG): Amyotrophic Lateral Sclerosis 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P5.012  

              Author Institution:Mitsubishi Tanabe Pharma Canada, Inc., Toronto, ON, Canada  IQVIA Solutions Canada, Inc., Mississauga, ON, Canada  Innomar Strategies, Oakville, ON, Canada  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ